190
Views
7
CrossRef citations to date
0
Altmetric
Device Profile

A new electronic device for subcutaneous injection of IFN-β-1a

, &
Pages 543-553 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Marcello Moccia, Raffaele Palladino, Cinzia Russo, Marco Massarelli, Antonio Nardone, Maria Triassi, Alessandra Lugaresi & Vincenzo Brescia Morra. (2015) How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis. Expert Opinion on Drug Delivery 12:12, pages 1829-1835.
Read now
Helen Willis, Julie Webster, Anne Marie Larkin & Laura Parkes. (2014) An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device. Patient Preference and Adherence 8, pages 843-851.
Read now
Mehmood Syed, David Rog, Laura Parkes & Gillian L Shepherd. (2014) Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice. Patient Preference and Adherence 8, pages 247-255.
Read now
Volker Limmroth & Kathrin Gerbershagen. (2014) Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a. Expert Opinion on Drug Delivery 11:12, pages 1969-1978.
Read now
Alessandra Lugaresi. (2013) RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence . Expert Opinion on Drug Delivery 10:2, pages 273-283.
Read now
Caroline D’Arcy, Del Thomas, Dee Stoneman & Laura Parkes. (2012) Patient assessment of an electronic device for subcutaneous self-injection of interferon β-1a for multiple sclerosis: an observational study in the UK and Ireland. Patient Preference and Adherence 6, pages 55-61.
Read now

Articles from other publishers (1)

O. Fernández, R. Arroyo, S. Martínez-Yélamos, M. Marco, J. A. García Merino, D. Muñoz, E. Merino & A. Roque. (2016) Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis. PLOS ONE 11:8, pages e0160313.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.